Mylan to Teva: Stick It

Mylan (MYL) gave it’s answer to Teva’s (TEVA) acquisition proposition: a resounding no, one that CNBC’s David Faber tweeted was “one of the most condescending, sarcastic and nasty letters” he’d come across. Citigroup’s Liav Abraham explains. The strong language used in Mylan’s letter rejecting TEVA’ s offer to acquire the company reaffirms the Board’s recent pre-emptive [...]